Enteric Coated Rabeprazole Sodium & Sustained Release Levosulpiride Capsules – Rabaval L Capsules

Rabaval L Capsules
Composition:- Enteric Coated Rabeprazole Sodium 20 mg & Sustained Release Levosulpiride 75 mg.

Rabaval L Capsules – This formulation of Enteric Coated Rabeprazole Sodium & Sustained Release Levosulpiride Capsules is a combination of Rabeprazole, a proton pump inhibitor (PPI), reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme, treats GERD, and aids in healing peptic ulcers and esophageal damage caused by excess acid; and Levosulpiride, a prokinetic agent, provides dual action by reducing stomach acid and improving gastrointestinal motility. It is highly effective in managing acid reflux, gastritis, and functional dyspepsia.

Key Points of Enteric Coated Rabeprazole Sodium & Sustained Release Levosulpiride Capsules – Rabaval L Capsules
• Dual Action Formula: Reduces stomach acid while enhancing gastric motility for better digestion
• More Effective than PPI Alone: Targets both acid suppression and gut motility, ensuring faster and more complete relief and reducing gastric irritation, nausea, and bloating in patients with chronic digestive issues.
• Broad symptom management: Effective in multiple conditions such as GERD, Indigestion, bloating, post-meal discomfort, IBS with Dyspepsia, and chronic gastritis.

Can be Prescribed by:
• General Physician
• Gastroenterologist
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.